Proof of concept (POC) animal study highlighting conduits treated with ADAPT® tissue technology demonstrated no
calcification evident. This was a milestone and a major step towards ADAPT® treated prosthetic conduits being utilised in
CABG (coronary artery bypass graft) surgeries.
800,000 surgeries using CABG per year
$16b market
Proof of concept (POC) animal study highlighting conduits...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.20 |
Change
-0.300(1.46%) |
Mkt cap ! $394.0M | |||
| Open | High | Low | Value | Volume |
| $20.40 | $20.40 | $20.20 | $15.14K | 747 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 810 | $20.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.39 | 185 | 1 |
View Market Depth
| Last trade - 10.37am 14/05/2024 (20 minute delay) ? |
| AVR (ASX) Chart |